Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?

Thrombosis Research

Volumn 121, Issue 6, 2008, Pages 743-750

  Linnemann, Birgit ^a   Schindewolf, Marc ^a   Zgouras, Dimitrios ^a   Erbe, Matthias ^a   Jarosch Preusche, Marie ^a   Lindhoff Last, Edelgard ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Arterial thrombosis; Ischemic stroke; Myocardial infarction; Thrombophilia; Venous thromboembolism

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; FEMALE; GENE MUTATION; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; STATISTICAL SIGNIFICANCE; STROKE; THROMBOEMBOLISM; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTIPHOSPHOLIPID; ANTITHROMBINS; ARTERIES; BRAIN ISCHEMIA; COHORT STUDIES; DATABASES, FACTUAL; FACTOR V; FACTOR VIII; FEMALE; GERMANY; HUMANS; INCIDENCE; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; MUTATION; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN C; PROTEIN S; PROTHROMBIN; REGISTRIES; RISK FACTORS; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 41849146788     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.07.014     Document Type: Article

References (41)

1. Heit J.A. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 3 (2005) 1611-1617
2. Galli M., Luciani G., Bertolini G., and Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systemic review of the literature. Blood 101 (2003) 1827-1832
3. Lalouschek W., Schillinger M., Hsieh K., Endler G., Tentschert S., Lang W., et al. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke 36 (2005) 1405-1409
4. Rosendaal F.R., Siscovick D.S., Schwartz S.M., Beverly R.K., Psaty B.M., Longstreth W.T., et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 89 (1997) 2817-2821
5. De Stefano V., Chiusolo P., Paciaroni K., Casorelli I., Rossi E., Molinar M., et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 91 (1998) 3562-3565
6. Grossmann R., Geisen U., Merati G., Mullges W., Schambeck C.M., Walter U., et al. Genetic risk factors in young adults with cryptogenic ischemic cerebrovascular disease. Blood Coagul Fibrinolysis 13 (2002) 583-590
7. Margaglione M., D'Andrea G., Giuliani, Brancaccio V., De Lucia D., Grandone E., et al. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 19 (1999) 1751-1756
8. Segev A., Ellis M.H., Segev F., Friedman Z., Reshef T., Sparkes J.D., et al. High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors. Int J Cardiol 98 (2005) 421-424
9. Ridker P.M., Hennekens C.H., Lindpaintner K., Stampfer M.J., Eisenberg P.R., and Miletich J.P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332 (1995) 912-917
10. Cushman M., Rosendaal F.R., Psaty B.M., Cook E.F., Valliere J., Kuller L.H., et al. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the cardiovascular health study. Thromb Haemost 79 (1998) 912-915
11. Juul K., Tybjaerg-Hansen A., Steffensen R., Kofoed S., Jensen G., and Nordestgaard B.G. Factor V Leiden: the Copenhagen City Heart Study and 2 meta-analyses. Blood 100 (2002) 3-10
12. The Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107 (2003) 1117-1122
13. Eikelboom J.W., Baker R.I., Parsons R., Taylor R.R., and van Bockxmeer F.M. No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease. Thromb Haemost 80 (1998) 878-880
14. Longstreth W.T., Rosendaal R.F., Siscovick D.S., Vos H.L., Schwartz S.M., Psaty B.M., et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke 29 (1998) 577-580
15. Lopaciuk S., Bykowska K., Kwiecinski H., Mickielewicz A., Czlonkowska A., Mendel T., et al. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 7 (2001) 346-350
16. Austin H., Chimowitz M.I., Hill H.A., Chaturvedi S., Wechsler L.R., Wityk R.J., et al. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke 33 (2002) 2762-2769
17. Madonna P., de Stefano V., Coppola A., Cirillo F., Cerbone A.M., Orefice G., et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 33 (2002) 51-56
18. Kim R.J., and Becker R.C. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146 (2003) 948-957
19. Brandt J.T., Triplett D.A., Alving B., and Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74 (1995) 1185-1190
20. Lindhoff-Last E., Humpich M., Schmitt J., Rödiger S., Seifried E., and Bauersachs R. MIXCON-LA: a precise, sensitive and specific aPTT-based assay for detection of lupus anticoagulant. Clin Appl Thromb Hemost 8 (2002) 163-167
21. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
22. Anderson F.A., and Spencer F.A. Risk factors for venous thromboembolism. Circulation 107 (2003) I-9-I-16
23. Koster T., Blann A.D., Briet E., Vandenbroucke J.P., and Rosendaal F.R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345 (1995) 152-155
24. Prandoni P., Ghirarduzzi A., Prins M.H., Pengo V., Davidson B.L., Sorensen H., et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 4 (2006) 1891-1896
25. Ford E.S., Giles W.H., and Croft J.B. Prevalence of nonfatal coronary heart disease among American adults. Am Heart J 139 (2000) 371-377
26. Muntner P., Garrett E., Klag M.J., and Coresh J. Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age. Stroke 33 (2002) 1209-1213
27. Ridker P.M., Hennekens C.H., and Miletich J.P. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 99 (1999) 999-1004
28. Smiles A.M., Jenny N.S., Tang Z., Arnold A., Cushman M., and Tracy R.P. No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease. Thromb Haemost 87 (2002) 614-621
29. French J.K., Van de Water N.S., Sutton T.M., Lund M., Gao W., McDowell J., et al. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction. Am Heart J 145 (2003) 118-124
30. Mansourati J., Da Costa A., Munier S., Mercier B., Tary B., Ferec C., et al. Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost 83 (2000) 822-825
31. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., and Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96 (1997) 1102-1108
32. Catto A.J., Carter A.M., Barrett J.H., Bamford J., Rice P.J., and Grant P.J. Von Willebrand factor and factor VIII:C in acute cerebrovascular disease: relationship to stroke subtype and mortality. Thromb Haemost 77 (1997) 1104-1108
33. Rice G.I., and Grant P.J. FVIII coagulant activity and antigen in subjects with ischaemic heart disease. Thromb Haemost 80 (1998) 757-762
34. Tracy R.P., Arnold A.M., Ettinger W., Fried L., Leilahn E., and Savage P. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 19 (1999) 1776-1783
35. Bank I., Libourel E.J., Middeldorp S., Hamulyak K., van Pampus E.C., Koopman M.M., et al. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J Thromb Haemost 3 (2005) 79-84
36. Kamphuisen P.W., Eikenboom J.C.J., and Bertina R.M. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 21 (2001) 731-738
37. Levine S.R. Hypercoagulable states and stroke: a selective review. CNS Spectr 10 (2005) 567-578
38. Levine J.S., Branch D.W., and Rauch J. The antiphospholipid syndrome. N Engl J Med 346 (2002) 752-763
39. Petri M. The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort. Thromb Res 114 (2004) 593-595
40. The APASS Writing Committee. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischaemic stroke. JAMA 291 (2004) 576-584
41. Brey R.L. Antiphospholipid antibodies in young adults with stroke. J Thromb Thrombolysis 20 (2005) 105-112